Shire Receives Approval of FIRAZYR (icatibant injection) for the Treatment of Hereditary Angioedema (HAE) Attacks in Japan
Shire Announces FDA Approval of TAKHZYRO (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema
New Drug Application Submitted in Japan for INTUNIV (guanfacine hydrochloride extended release) in Adults with ADHD
Blue Jay Gold Details Fully Funded Exploration Program at Steller Gold Project in Yukon and Confirms Listing Date
The Supply Gap No One Is Filling: How CHARBONE Is Building the UHP Industrial Gas Platform Big Players Won't
QIMC Appears Before Quebec National Assembly on Bill 17, Highlighting Quebec's Natural Hydrogen Potential
